Introduction: Two Kinds of Crushing Cancer Bills
Related Articles
Learn more about [why choose China for cancer treatment](https://mymedvia.com/cancer-treatment-in-china/why-choose-china-for-cancer-treatment-2026-complete-guide/) and [top cancer hospitals in China](https://mymedvia.com/cancer-treatment-in-china/top-cancer-hospitals-in-china-2026-guide-for-international-patients/).
Cancer costs crush patients in two ways:
In the US: The bill itself is astronomical. CAR-T at $373K-$525K per dose, immunotherapy $20K/month median. Even insured patients may pay $10K+/year out-of-pocket.
On the NHS: The bill is "free" — but the cost is measured in waiting. The 62-day target is met by only 3/121 trusts. NICE approves only ~40% of new cancer drugs.
This article provides verifiable cancer cost comparisons.
1. CAR-T Cell Therapy Cost Comparison
| Region | Per Dose (USD) | Notes |
|---|---|---|
| 🇺🇸 USA | $373,000-$525,000 | Some exceed $1M total |
| 🇬🇧 NHS | £0 (if NICE-approved) | Only ~40% of new drugs approved |
| 🇬🇧 UK Private | £200,000+ (~$254,000+) | Very few centers |
| 🇨🇳 China | ~$141,000-$182,000 | ~1/3 of US; prices trending down |
China CAR-T Products
| Brand | Indication | China Price (¥) | USD ($) |
|---|---|---|---|
| Yikaida (Fosun Kite) | DLBCL lymphoma | ~¥1,200,000 | ~$169,000 |
| BeiNuoda (JW Therapeutics) | DLBCL lymphoma | ~¥1,290,000 | ~$182,000 |
| Yuanruida (Heyuan Bio) | ALL | ~¥999,000 | ~$141,000 |
| Fukesu (Xunluo Bio) | Multiple myeloma | ~¥1,166,000 | ~$165,000 |
| Saikaize (Kezhi Pharma) | Multiple myeloma | ~¥1,150,000 | ~$162,000 |
Sources: [PharmaCube, "CAR-T overseas patients"](https://bydrug.pharmcube.com/news/detail/e27b99b3bf9a78db12450e3c45435edf); [Yicai, "Overseas cancer patients seek drugs"](https://m.yicai.com/news/102937896.html)
Real Case
| Item | USA/Australia | China |
|---|---|---|
| CAR-T cost | $373,000-$525,000 | ~$141,000-$182,000 |
| NZ patient Stu Lye | NZD ~$1,000,000 | NZD ~$150,000 (~$90,000) |
| Full cycle | Months | 5-7 weeks |
2. Immunotherapy Cost Comparison (Annual)
| Drug | USA ($/year) | China ($/year) |
|---|---|---|
| Pembrolizumab (Keytruda) | ~$170,000 | ~$30,000-$40,000 |
| Nivolumab (Opdivo) | ~$160,000 | ~$25,000-$35,000 |
| Atezolizumab (Tecentriq) | ~$178,000 | ~$30,000-$45,000 |
| Tislelizumab (domestic PD-1) | Not available | ~$15,000-$20,000 |
| Sintilimab (domestic PD-1) | Not available | ~$10,000-$15,000 |
US oncology drugs median monthly price: $20,000 (The Lancet Oncology, 2024). China's domestic PD-1 drugs cost less than half of imported equivalents, with non-inferior efficacy in clinical studies.
Sources: [The Lancet Oncology, Aug 2024](https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(24)00286-9/fulltext); [ISPOR 2024](https://www.ispor.org/heor-resources/presentations-database/presentation/intl2024-3898/137687)
3. Common Cancer Comprehensive Treatment Costs
Lung Cancer
| Stage | USA ($) | China ($) |
|---|---|---|
| Early (surgery + follow-up) | $50,000-$100,000 | $7,000-$14,000 |
| Mid-advanced (surgery + chemo/radio) | $100,000-$250,000 | $21,000-$35,000 |
| Advanced (immuno + targeted, 1st yr) | $200,000-$500,000 | $42,000-$70,000 |
Liver Cancer
| Treatment | USA ($) | China ($) |
|---|---|---|
| Early surgery/ablation (5 yr) | $100,000-$200,000 | $21,000-$42,000 |
| Advanced combo (targeted, 5 yr) | $300,000-$600,000 | $70,000-$141,000 |
| Liver transplant | $500,000+ | $50,000-$100,000 |
Colorectal Cancer
| Stage | USA ($) | China ($) |
|---|---|---|
| Early (surgery, 5 yr) | $80,000-$150,000 | $14,000-$28,000 |
| Advanced (surgery + chemo + targeted) | $200,000-$500,000 | $56,000-$113,000 |
Breast Cancer
| Treatment | USA ($) | China ($) |
|---|---|---|
| Early (lumpectomy/mastectomy + radiation) | $60,000-$130,000 | $10,000-$20,000 |
| HER2+ (targeted, 1 yr) | $150,000-$250,000 | $30,000-$50,000 |
| Advanced (comprehensive) | $200,000-$400,000 | $40,000-$80,000 |
Source: [Fudah Hospital, "Cancer Treatment Cost in China"](https://phl.fudahospital.com/fudanews/latestnews/3518.html)
4. Diagnostic Cost Comparison
| Test | USA ($) | UK Private (£/$) | China ($) |
|---|---|---|---|
| PET-CT | $3,000-$6,000 | £1,500-£2,500 (~$1,900-$3,200) | $1,000-$1,500 |
| MRI (contrast) | $1,500-$4,000 | £500-£1,000 (~$635-$1,270) | $250-$550 |
| CT scan | $1,000-$3,000 | £300-£600 (~$380-$760) | $200-$400 |
| Tumor marker panel | $500-$1,500 | £200-£500 (~$254-$635) | $100-$200 |
| Genetic testing (NGS) | $3,000-$6,000 | £1,500-£3,000 (~$1,900-$3,800) | $800-$1,500 |
5. NHS: Free But Restricted
62-day target: Only 3/121 trusts meet it2024/25: Nearly 30,000 patients waited >104 daysNICE approvals: Only ~40% of new cancer drugs approvedUK private: Costs match or exceed US prices> Sources: [BBC, "Nearly all NHS hospitals missing cancer targets"](https://www.bbc.co.uk/news/articles/cgjdpqvpj3lo); [The Lancet Oncology, Project Orbis Study](https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(24)00286-9/fulltext) > >
6. Total Cost Including Travel
Scenario: US patient, advanced lung cancer, immuno+targeted 1st year
| Cost Item | USA ($) | China ($) |
|---|---|---|
| Treatment (1 year) | ~$300,000 | ~$60,000 |
| Flights + visa | — | ~$3,000 |
| Accommodation (6 weeks intermittent) | — | ~$3,000 |
| mymedvia Full Concierge | — | ~$1,000 |
| Total | ~$300,000 | ~$67,000 |
Savings: ~$233,000 (78%)
Scenario: UK patient, NICE rejected new drug + waiting >3 months
| Option | Cost | Time | Risk |
|---|---|---|---|
| Continue NHS wait | £0 | Another 3-6 months | Disease may progress |
| Treatment in China (immuno + targeted, 1st yr) | ~$65,000 | Treatment within 2 weeks | No delay |
7. Important Notes
Foreign patients cannot access Chinese public insurance pricing. Self-pay rates still far below US levels.Prices vary by hospital and city. Beijing/Shanghai international departments charge more but offer English services.Domestic PD-1/HER2 drugs are 30%-50% cheaper than imports, with non-inferior efficacy in clinical studies.Some hospitals accept international insurance direct billing. Confirm when booking.mymedvia confirms complete cost breakdowns — no hidden charges.---
Contact mymedvia through our website. Tell us your diagnosis. We'll provide a personalized treatment recommendation and cost estimate within 24 hours.
mymedvia — Cancer treatment shouldn't cost the earth.